Device type · PRD
Product code PRD
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
PRD
Not in our classification list
Device class
n/a
FDA decisions since 2015
3
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Product code
- PRD
- FDA record
- Classification database entry for PRD
Latest FDA decisions
K243822 · Decided Mar 12, 2025 · 90 days after receipt
Device type: Product code (PRD) · Laboratory Medicine & Pathology
K170883 · Decided Jun 22, 2017 · 90 days after receipt
Device type: Product code (PRD) · Laboratory Medicine & Pathology
- FilmArray NGDS Warrior PanelNew device typeDe Novo
DEN160048 · Decided Feb 14, 2017 · 120 days after receipt
Device type: Product code (PRD) · Laboratory Medicine & Pathology
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2877-2026 · Started Jul 16, 2026 · Posted by FDA Aug 4, 2026
Reason given: Firm has identified mismatches between the outbreak strain and the reference strain used in the development of its qualitative, multiplexed, nucleic acid-based in vitro diagnostic panel test.
Cause as FDA categorized it: Under Investigation by firm
Z-2609-2025 · Started Jul 10, 2025 · Posted by FDA Sep 19, 2025
Reason given: FilmArray NGDS Warrior Panel (NGDS-ASY-0007) has an increased risk of internal control failures when testing positive blood culture, which may lead to delayed results and additional diagnostic workup.
Cause as FDA categorized it: Component design/selection
Z-1448-2020 · Started Aug 20, 2019 · Posted by FDA Feb 18, 2020
Reason given: The firm has identified that an incorrect instruction for use (IFU) revision was included in the qualitative, multiplexed, nucleic acid-based in vitro diagnostic test kit.
Cause as FDA categorized it: Labeling Change Control
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.